Clinical Trial Update: Nimotuzumab in Adults With Glioblastoma Multiforma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating nimotuzumab in adults with glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Oncoscience AG | Conditions: Adults With Glioblastoma Multiforma | Phase 3 | Status: COMPLETED